Proteomic analysis of the host response in the bursa of Fabricius of chickens infected with Marek's disease virus

Virus Research

Volumn 153, Issue 2, 2010, Pages 250-257

  Lu, Zhanjun ^a   Qin, Aijian ^a   Qian, Kun ^a   Chen, Xinhong ^a   Jin, Wenjie ^a   Zhu, Yufeng ^a   Eltahir, Y M ^a  

^a YANGZHOU UNIVERSITY   (China)

Author keywords

Bursa of Fabricius; Marek's disease virus; Mass spectrometry; Proteomic; Two dimensional gel electrophoresis

Indexed keywords

APOLIPOPROTEIN A1; BETA 2 MICROGLOBULIN; FRUCTOSE BISPHOSPHATE ALDOLASE; GUANOSINE TRIPHOSPHATASE; HEAT SHOCK PROTEIN 27; PHOSPHOMANNOMUTASE; PROTEOME; STATHMIN; TROPONIN T; TRYPSINOGEN;

ARTICLE; BURSA FABRICII; CARCINOGENESIS; CELL PROLIFERATION; CHICKEN; IMMUNE RESPONSE; MARDIVIRUS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; VIRUS INFECTIVITY;

ANIMALS; BURSA OF FABRICIUS; CHICKENS; DOWN-REGULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HOST-PATHOGEN INTERACTIONS; MARDIVIRUS; MAREK DISEASE; PROTEOME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; UP-REGULATION;

GALLID HERPESVIRUS 2; GALLUS GALLUS; HERPESVIRIDAE;

EID: 77957280683     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2010.08.010     Document Type: Article

References (51)

1. Abdul-Careem M.F., Hunter B.D., Sarson A.J., Parvizi P., et al. Host responses are induced in feathers of chickens infected with Marek's disease virus. Virology 2008, 370:323-332.
2. Abdul-Careem M.F., Hunter B.D., Lee L.F., Fairbrother J.H., et al. Host responses in the bursa of Fabricius of chickens infected with virulent Marek's disease virus. Virology 2008, 379:256-265.
3. Babu J.R., Jeganathan K.B., Baker D.J., Wu X., et al. Rae1 is an essential mitotic checkpoint regulator that cooperates with Bub3 to prevent chromosome missegregation. J. Cell Biol. 2003, 160:341-353.
4. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
5. Braunstein I., Miniowitz S., Moshe Y., Hershko A. Inhibitory factors associated with anaphase-promoting complex/cylosome in mitotic checkpoint. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:4870-4875.
6. Burgess S.C., Young J.R., Baaten B.J., Hunt L., et al. Marek's disease is a natural model for lymphomas overexpressing Hodgkin's disease antigen (CD30). Proc. Natl. Acad. Sci. U.S.A. 2004, 101:13879-13884.
7. Calnek B.W. Pathogenesis of Marek's disease virus infection. Curr. Top. Microbiol. Immunol. 2001, 255:25-55.
8. Candiano G., Bruschi M., Musante L., Santucci L., et al. Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis 2004, 25:1327-1333.
9. Chaudhry A., Das S.R., Jameel S., George A., et al. HIV-1 Nef induces a Rab11-dependent routing of endocytosed immune costimulatory proteins CD80 and CD86 to the Golgi. Traffic 2008, 9:1925-1935.
10. Chen G., Wang H., Gharib T.G., Huang C.C., et al. Overexpression of oncoprotein 18 correlates with poor differentiation in lung adenocarcinomas. Mol. Cell. Proteomics 2003, 2:107-116.
11. Coghlin C., Carpenter B., Dundas S.R., Lawrie L.C., et al. Characterization and over-expression of chaperonin t-complex proteins in colorectal cancer. J. Pathol. 2006, 210:351-357.
12. Curmi P.A., Nogues C., Lachkar S., Carelle N., et al. Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours. Br. J. Cancer 2000, 82:142-150.
13. Das K.C. c-Jun NH2-terminal kinase-mediated redox-dependent degradation of IkappaB: role of thioredoxin in NF-kappaB activation. J. Biol. Chem. 2001, 276:4662-4670.
14. Eom C.Y., Lehman I.R. The human DnaJ protein, hTid-1, enhances binding of a multimer of the herpes simplex virus type 1 UL9 protein to oris, an origin of viral DNA replication. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:1894-1898.
15. Feldman D.E., Thulasiraman V., Ferreyra R.G., Frydman J. Formation of the VHL-elongin BC tumor suppressor complex is mediated by the chaperonin TRiC. Mol. Cell 1999, 4:1051-1061.
16. Gimeno I.M., Witter R.L., Fadly A.M., Silva R.F. Novel criteria for the diagnosis of Marek's disease virus-induced lymphomas. Avian Pathol. 2005, 34:332-340.
17. Glinsky G.V. Genomic models of metastatic cancer: functional analysis of death-from-cancer signature genes reveals aneuploid, anoikis-resistant, metastasis-enabling phenotype with altered cell cycle control and activated Polycomb Group (PcG) protein chromatin silencing pathway. Cell Cycle 2006, 5:1208-1216.
18. Grosshans B.L., Ortiz D., Novick P. Rabs and their effectors: achieving specificity in membrane traffic. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:11821-11827.
19. Higuchi T., Watanabe Y., Waga I. Protein disulfide isomerase suppresses the transcriptional activity of NF-kappaB. Biochem. Biophys. Res. Commun. 2004, 318:46-52.
20. Hu J., Ma X., Lindner D.J., Karra S., et al. Modulation of p53 dependent gene expression and cell death through thioredoxin-thioredoxin reductase by the Interferon-Retinoid combination. Oncogene 2001, 20:4235-4248.
21. Jarosinski K.W., Njaa B.L., O'Connell P.H., Schat K.A. Pro-inflammatory responses in chicken spleen and brain tissues after infection with very virulent plus Marek's disease virus. Viral Immunol. 2005, 18:148-161.
22. Jarosinski K.W., Tischer B.K., Trapp S., Osterrieder N. Marek's disease virus: lytic replication, oncogenesis and control. Expert Rev. Vaccines 2006, 5:761-772.
23. Jarosinski K.W., Margulis N.G., Kamil J.P., Spatz S.J., et al. Horizontal transmission of Marek's disease virus requires US2, the UL13 protein kinase, and gC. J. Virol. 2007, 81:10575-10587.
24. Johnsen J.I., Aurelio O.N., Kwaja Z., Jorgensen G.E., et al. p53-mediated negative regulation of stathmin/Op18 expression is associated with G(2)/M cell-cycle arrest. Int. J. Cancer 2000, 88:685-691.
25. Kalitsis P., Fowler K.J., Griffiths B., Earle E., et al. Increased chromosome instability but not cancer predisposition in haploinsufficient Bub3 mice. Genes Chromosomes Cancer 2005, 44:29-36.
26. Kashuba E., Pokrovskaja K., Klein G., Szekely L. Epstein-Barr virus-encoded nuclear protein EBNA-3 interacts with the epsilon-subunit of the T-complex protein 1 chaperonin complex. J. Hum. Virol. 1999, 2:33-37.
27. Knoblach B., Keller B.O., Groenendyk J., Aldred S., et al. ERp19 and ERp46, new members of the thioredoxin family of endoplasmic reticulum proteins. Mol. Cell. Proteomics 2003, 2:1104-1119.
28. Lim S.O., Park S.G., Yoo J.H., Park Y.M., et al. Expression of heat shock proteins (HSP27, HSP60, HSP70, HSP90, GRP78, GRP94) in hepatitis B virus-related hepatocellular carcinomas and dysplastic nodules. World J. Gastroenterol. 2005, 11:2072-2079.
29. Lingappa J.R., Martin R.L., Wong M.L., Ganem D., et al. A eukaryotic cytosolic chaperonin is associated with a high molecular weight intermediate in the assembly of hepatitis B virus capsid, a multimeric particle. J. Cell Biol. 1994, 125:99-111.
30. Marone M., Mozzetti S., De Ritis D., Pierelli L., Scambia G. Semiquantitative RT-PCR analysis to assess the expression levels of multiple transcripts from the same sample. Biol. Proc. Online 2001, 3:19-25.
31. Mehlen P., Mehlen A., Guillet D., Preville X., Arrigo A.P. Tumor necrosis factor-alpha induces changes in the phosphorylation, cellular localization, and oligomerization of human hsp27, a stress protein that confers cellular resistance to this cytokine. J. Cell. Biochem. 1995, 58:248-259.
32. Melle C., Ernst G., Winkler R., Schimmel B., et al. Proteomic analysis of human papillomavirus-related oral squamous cell carcinoma: identification of thioredoxin and epidermal-fatty acid binding protein as upregulated protein markers in microdissected tumor tissue. Proteomics 2009, 9:2193-2201.
33. Mistry S.J., Bank A., Atweh G.F. Targeting stathmin in prostate cancer. Mol. Cancer Ther. 2005, 4:1821-1829.
34. Muniyappa H., Song S., Mathews C.K., Das K.C. Reactive oxygen species-independent oxidation of thioredoxin in hypoxia: Inactivation of ribonucleotide reductase and redox-mediated checkpoint control. J. Biol. Chem. 2009, 284:17069-17081.
35. Murray J.L., Mavrakis M., McDonald N.J., Yilla M., et al. Rab9 GTPase is required for replication of human immunodeficiency virus type 1, filoviruses, and measles virus. J. Virol. 2005, 79:11742-11751.
36. Nissom P.M., Lo S.L., Lo J.C., Ong P.F., et al. Hcc-2, a novel mammalian ER thioredoxin that is differentially expressed in hepatocellular carcinoma. FEBS Lett. 2006, 580:2216-2226.
37. Osterrieder N., Kamil J.P., Schumacher D., Tischer B.K., Trapp S. Marek's disease virus: from miasma to model. Nat. Rev. Microbiol. 2006, 4:283-294.
38. Pan F.G., Zheng M.Z., Li H., Zou Y.X., et al. Effect on expression of p53 gene in chicken embryo fibroblasts by MDV meq gene. Chin J. Vet. Sci. 2008, 28:243-246.
39. Price D.K., Ball J.R., Bahrani-Mostafavi Z., Vachris J.C., et al. The phosphoprotein Op18/stathmin is differentially expressed in ovarian cancer. Cancer Invest. 2000, 18:722-730.
40. Quere P., Rivas C., Ester K., Novak R., Ragland W.L. Abundance of IFN-alpha and IFN-gamma mRNA in blood of resistant and susceptible chickens infected with Marek's disease virus (MDV) or vaccinated with turkey herpesvirus; and MDV inhibition of subsequent induction of IFN gene transcription. Arch. Virol. 2005, 150:507-519.
41. Rocchi P., So A., Kojima S., Signaevsky M., et al. Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer. Cancer Res. 2004, 64:6595-6602.
42. Roos G., Brattsand G., Landberg G., Marklund U., Gullberg M. Expression of oncoprotein 18 in human leukemias and lymphomas. Leukemia 1993, 7:1538-1546.
43. Rowe R.K., Suszko J.W., Pekosz A. Roles for the recycling endosome, Rab8, and Rab11 in hantavirus release from epithelial cells. Virology 2008, 382:239-249.
44. Schat K.A., Calnek B.W., Fabricant J. Influence of the bursa of Fabricius on the pathogenesis of Marek's disease. Infect. Immun. 1981, 31:199-207.
45. Schat K.A., Calnek B.W., Fabricant J. Characterisation of two highly oncogenic strains of Marek's disease virus. Avian Pathol. 1982, 11:593-605.
46. Srinivas R.V., Birkedal B., Owens R.J., Anantharamaiah G.M., et al. Antiviral effects of apolipoprotein A-I and its synthetic amphipathic peptide analogs. Virology 1990, 176:48-57.
47. Srinivas R.V., Venkatachalapathi Y.V., Rui Z., Owens R.J., et al. Inhibition of virus-induced cell fusion by apolipoprotein A-I and its amphipathic peptide analogs. J. Cell. Biochem. 1991, 45:224-237.
48. Thanthrige-Don N., Abdul-Careem M.F., Shack L.A., Burgess S.C., Sharif S. Analyses of the spleen proteome of chickens infected with Marek's disease virus. Virology 2009, 390:356-367.
49. Thanthrige-Don N., Parvizi P., Sarson A.J., Shack L.A., et al. Proteomic analysis of host responses to Marek's disease virus infection in spleens of genetically resistant and susceptible chickens. Dev. Comp. Immunol. 2010, 34:699-704.
50. Xi W., Rui W., Fang L., Ke D., et al. Expression of stathmin/op18 as a significant prognostic factor for cervical carcinoma patients. J. Cancer Res. Clin. Oncol. 2009, 135:837-846.
51. Zhang H., Luo Y., Zhang W., He Y., et al. Endothelial-specific expression of mitochondrial thioredoxin improves endothelial cell function and reduces atherosclerotic lesions. Am. J. Pathol. 2007, 170:1108-1120.